Stay updated with breaking news from Reduce Burden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As Previously Announced, Reldesemtiv Had No Effect on the Primary Endpoint of Change from Baseline in ALSFRS-R or Key Secondary Endpoints Trial Discontinued…
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated CYTK today announced five presentations at the 34th International…
Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Focus on...
'To Kill a Mocking Bird'
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Global Glaucoma Surgery Devices Market (2023-2028) by Product, Surgery Method, End-Users, and Geography,...